Justin Zelin

Justin Zelin

Analyst-Equity chez
BTIG LLC
Finance
Health Technology
Consumer Services

Profil

Mr. Justin Zelin is a Director at BTIG LLC.
His research coverage focuses on the biotechnology sector, where he specializes in cell therapy, targeted oncology, immunology and auto-immune disease therapeutics.
Prior to BTIG, Mr. Zelin was a Biotech Equity Research Analyst at B. Riley Securities.
Previously, he held biotech equity research associate roles at Canaccord Genuity and SVB Leerink.
Earlier in his career, Mr. Zelin worked in both academic and industry labs including Agenus, Harvard University and Brigham and Women’s Hospital.
He was also a member of Harvard University’s teaching staff for more than five years.
He earned a master’s degree in biotechnology and a bachelor’s degree in biology from Harvard University.

Postes actifs de Justin Zelin

SociétésPosteDébut
Analyst-Equity 01/01/2021

Anciens postes connus de Justin Zelin

SociétésPosteFin
Analyst-Equity 01/12/2020
Analyst-Equity 01/07/2020
Corporate Officer/Principal 01/04/2019
AGENUS INC. Corporate Officer/Principal 01/09/2016
Voir l'expérience en détail de Justin Zelin

Formation de Justin Zelin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

81

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Finance

Finance

Finance

Finance

  1. Bourse
  2. Insiders
  3. Justin Zelin
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT